Danping Liu

1.0k total citations · 1 hit paper
19 papers, 679 citations indexed

About

Danping Liu is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Danping Liu has authored 19 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 7 papers in Infectious Diseases and 7 papers in Hepatology. Recurrent topics in Danping Liu's work include Liver Disease Diagnosis and Treatment (8 papers), Hepatitis C virus research (6 papers) and Hepatitis B Virus Studies (5 papers). Danping Liu is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Hepatitis C virus research (6 papers) and Hepatitis B Virus Studies (5 papers). Danping Liu collaborates with scholars based in China, United States and United Kingdom. Danping Liu's co-authors include Dan Huang, Jun Chen, Hongzhou Lu, Yinzhong Shen, Li Liu, Lu Xia, Yun Ling, Qingnian Xu, Shuli Song and Zhiping Qian and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Clinical Pathology and International Journal of Antimicrobial Agents.

In The Last Decade

Danping Liu

16 papers receiving 662 citations

Hit Papers

[A pilot study of hydroxychloroquine in treatment of pati... 2020 2026 2022 2024 2020 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. [A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19].
    2020 490 citations Jun Chen, Danping Liu et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danping Liu China 8 482 218 159 87 72 19 679
Zhiping Qian China 11 462 1.0× 216 1.0× 182 1.1× 88 1.0× 124 1.7× 25 886
Gui‐Qiang Wang China 7 539 1.1× 229 1.1× 224 1.4× 92 1.1× 197 2.7× 11 979
Amy Hirsch Shumaker United States 5 703 1.5× 368 1.7× 148 0.9× 58 0.7× 6 0.1× 9 876
Lianfeng Lu China 8 554 1.1× 260 1.2× 85 0.5× 72 0.8× 10 0.1× 21 758
Ina Jeong South Korea 11 302 0.6× 70 0.3× 92 0.6× 51 0.6× 18 0.3× 33 507
Mehtap Aydın Türkiye 14 152 0.3× 41 0.2× 156 1.0× 72 0.8× 26 0.4× 54 544
S. T. Lai China 9 516 1.1× 114 0.5× 209 1.3× 70 0.8× 190 2.6× 19 740
Shuli Song China 8 531 1.1× 245 1.1× 77 0.5× 124 1.4× 3 0.0× 12 710

Countries citing papers authored by Danping Liu

Since Specialization
Citations

This map shows the geographic impact of Danping Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danping Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danping Liu more than expected).

Fields of papers citing papers by Danping Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danping Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danping Liu. The network helps show where Danping Liu may publish in the future.

Co-authorship network of co-authors of Danping Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Danping Liu. A scholar is included among the top collaborators of Danping Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danping Liu. Danping Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Xu, Wei, Danping Liu, Renfang Zhang, Jun Chen, & Yinzhong Shen. (2025). Evaluation of ten diagnostic models for metabolic dysfunction-associated fatty liver disease in lean people living with HIV. BMC Infectious Diseases. 25(1). 1147–1147.
2.
Qin, Jinghui, et al.. (2025). Mental-Perceiver: Audio-Textual Multi-Modal Learning for Estimating Mental Disorders. Proceedings of the AAAI Conference on Artificial Intelligence. 39(23). 25029–25037. 1 indexed citations
3.
4.
Xun, Jingna, Rong Chen, Qi Tang, et al.. (2022). Circulating (1 → 3)-β-D-Glucan as an immune activation marker decreased after ART in people living with HIV. Frontiers in Public Health. 10. 981339–981339. 2 indexed citations
5.
Liu, Danping, Ling Gu, Renfang Zhang, et al.. (2022). Utility of urine lipoarabinomannan (LAM) in diagnosing mycobacteria infection among hospitalized HIV-positive patients. International Journal of Infectious Diseases. 118. 65–70. 7 indexed citations
6.
Liu, Li, Zichen Song, Jingna Xun, et al.. (2022). PD-1 Inhibitor for Disseminated Mycobacterium avium Infection in a Person With HIV. Open Forum Infectious Diseases. 10(1). 4 indexed citations
7.
Liu, Danping, et al.. (2022). Vitamin B6 Metabolic Pathway is Involved in the Pathogenesis of Liver Diseases via Multi-Omics Analysis. SHILAP Revista de lepidopterología. Volume 9. 729–750. 6 indexed citations
8.
Chen, Jun, Danping Liu, Lin Yin, Lijun Zhang, & Hongzhou Lu. (2021). Can we use hydroxychloroquine to treat COVID-19 now?. International Journal of Antimicrobial Agents. 57(1). 106173–106173. 1 indexed citations
9.
Chen, Jun, Renfang Zhang, Li Liu, et al.. (2021). Clinical usefulness of metagenomic next-generation sequencing for the diagnosis of central nervous system infection in people living with HIV. International Journal of Infectious Diseases. 107. 139–144. 20 indexed citations
10.
11.
Chen, Jun, Xiaomin Liu, Xinyu Zhang, et al.. (2021). Decline in neutralising antibody responses, but sustained T‐cell immunity, in COVID‐19 patients at 7 months post‐infection. Clinical & Translational Immunology. 10(7). e1319–e1319. 33 indexed citations
12.
Zhang, Zhanqing, Bisheng Shi, Wei Lu, et al.. (2020). Quantitative HBcrAg and HBcAb versus HBsAg and HBV DNA in predicting liver fibrosis levels of chronic hepatitis B patients. Gastroenterología y Hepatología. 43(9). 526–536. 9 indexed citations
13.
Liu, Danping, Tong Xu, Bisheng Shi, et al.. (2020). Clinical relevance of the in situ assay for HBV DNA: a cross-sectional study in patients with chronic hepatitis B. Journal of Clinical Pathology. 73(12). 813–818. 8 indexed citations
14.
Chen, Jun, Danping Liu, Li Liu, et al.. (2020). [A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19].. PubMed. 49(2). 215–219. 490 indexed citations breakdown →
15.
Liu, Danping, Yinzhong Shen, Renfang Zhang, et al.. (2020). Prevalence and risk factors of metabolic associated fatty liver disease among people living with HIV in China. Journal of Gastroenterology and Hepatology. 36(6). 1670–1678. 18 indexed citations
16.
Zhang, Zhanqing, Bisheng Shi, Wei Lu, et al.. (2020). Quantitative HBcrAg and HBcAb versus HBsAg and HBV DNA in predicting liver fibrosis levels of chronic hepatitis B patients. Gastroenterología y Hepatología (English Edition). 43(9). 526–536.
17.
Zhang, Zhanqing, Bisheng Shi, Wei Lu, et al.. (2019). Quantitative Anti-HBc in Liver Pathological States in Patients with Chronic Hepatitis B Virus Infection. Canadian Journal of Infectious Diseases and Medical Microbiology. 2019. 1–12. 7 indexed citations
18.
Liu, Danping, Wei Lu, Zhanqing Zhang, et al.. (2017). Comparative evaluation of GPR versus APRI and FIB‐4 in predicting different levels of liver fibrosis of chronic hepatitis B. Journal of Viral Hepatitis. 25(5). 581–589. 40 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhiping Qian Breakdown of academic impact, for papers by Gui‐Qiang Wang Breakdown of academic impact, for papers by Amy Hirsch Shumaker Breakdown of academic impact, for papers by Lianfeng Lu Breakdown of academic impact, for papers by Ina Jeong Breakdown of academic impact, for papers by Mehtap Aydın Breakdown of academic impact, for papers by S. T. Lai Breakdown of academic impact, for papers by Shuli Song
Rankless by CCL
2026